Amedeo Smart

Free Medical Literature Service


 

Amedeo

Rehabilitation Medicine

  Free Subscription

Articles published in
J Neurol
    March 2026
  1. ZHAO R, Hao T, Wang C, Wu L, et al
    Effect of noninvasive brain stimulation for unilateral spatial neglect after stroke: a systematic review and meta-analysis.
    J Neurol. 2026;273:232.
    >> Share

  2. ANDERSEN LK, Birnbaum S, Missel M, Petersen KG, et al
    Assessing respiratory status in myasthenia gravis: limited value of the MG-ADL as a standalone tool compared with spirometry in a Danish cohort.
    J Neurol. 2026;273:231.
    >> Share

  3. FIDAN C
    Technologies used in Parkinson's disease: a meta-analysis of their effect on health-related quality of life.
    J Neurol. 2026;273:203.
    >> Share

  4. LIU C, Jin Y, Lin H, Zheng Y, et al
    Effects of transcutaneous auricular vagus nerve stimulation on motor and gait performance in Parkinson's disease: a meta-analysis of randomized controlled trials.
    J Neurol. 2026;273:196.
    >> Share

    February 2026
  5. PELOUTO F, Papri N, Haagsma JA, Cornblath DR, et al
    Measurement properties of the Inflammatory Rasch-built Overall Disability Scale (I-RODS) in patients with Guillain-Barre syndrome.
    J Neurol. 2026;273:164.
    >> Share

  6. SANDROFF BM, Motl RW, Nauman H, Wells GE, et al
    Feasibility of a 12-month, remotely delivered and supported aerobic walking exercise training program for brain and cognition in adults with multiple sclerosis.
    J Neurol. 2026;273:162.
    >> Share

  7. EGGER M, Strobl R, Vogelgesang L, Reitelbach J, et al
    Evaluation of a multidisciplinary neurological rehabilitation program for the post-COVID-19 condition.
    J Neurol. 2026;273:159.
    >> Share

  8. ZENG B, Wang H, Chen J, Wu S, et al
    Optimal exercise modalities and doses for improving quality of life in patients with Parkinson's disease: a network meta-analysis and dose-response study.
    J Neurol. 2026;273:123.
    >> Share

  9. TECKENBURG I, Sidoroff V, Moradi H, Sapienza S, et al
    Construct validity of instrumented gait assessments in hospital and daily life mobility in patients with Parkinson's disease and atypical Parkinson's syndromes: an exploratory study.
    J Neurol. 2026;273:122.
    >> Share

    January 2026
  10. MAMMEN JR, Reddy V, Lerner A, Shah N, et al
    Three years later: tracking bothersome symptoms and impacts for people with early Parkinson's disease.
    J Neurol. 2026;273:93.
    >> Share

  11. GYGER N, Monschein T, Filser M, Batge S, et al
    Cognitive training, exercise training or combined training? A comparative effectiveness research study on subjective and objective cognitive outcomes in multiple sclerosis.
    J Neurol. 2026;273:82.
    >> Share

  12. LEEUWENBERG KE, van Alfen N, van de Warrenburg BP, Maas RPPWM, et al
    Peripheral and autonomic nervous system involvement in spinocerebellar ataxia type 3: unveiling an invisible burden.
    J Neurol. 2026;273:64.
    >> Share

    December 2025
  13. BRAADT L, Naumann M, Freuer D, Meisinger C, et al
    Chronic vertigo and dizziness signal unmet needs in stroke recovery.
    J Neurol. 2025;273:26.
    >> Share

  14. PREMARATNE S, Zoghi M, Antonic-Baker A, Chen Z, et al
    Non-invasive neurostimulation for drug-resistant epilepsy: systematic review and meta-analysis of effectiveness, safety, and optimal stimulation parameters.
    J Neurol. 2025;273:7.
    >> Share

    November 2025
  15. VICINO A, Lauletta A, Bonanno S, Barbaccia A, et al
    Assessment of IBM-FRS total score and specific functional domains in a large cohort of inclusion body myositis patients.
    J Neurol. 2025;272:775.
    >> Share

    October 2025
  16. SU X, Zheng Z, Yu F, Liu C, et al
    The impact of different exercise types on cognitive function in patients with multiple sclerosis: a systematic review and network meta-analysis.
    J Neurol. 2025;272:709.
    >> Share

  17. BRIL V, Antozzi C, Berkowicz T, Druzdz A, et al
    Self-administration of rozanolixizumab via manual push and infusion pump methods in patients with generalised myasthenia gravis: a randomised, phase 3, open-label, crossover study.
    J Neurol. 2025;272:686.
    >> Share

    September 2025
  18. BUONOCORE J, Iaccino N, Torchia G, Curcio F, et al
    Cognitive stimulation in Parkinson's disease with mild cognitive impairment.
    J Neurol. 2025;272:658.
    >> Share

  19. ROMANO F, Rocca MA, Pagani E, Amato MP, et al
    Effects of cognitive rehabilitation and exercise on brain structure in progressive multiple sclerosis: results from the CogEx trial.
    J Neurol. 2025;272:645.
    >> Share

  20. WENNINGER S, Heidsieck E, Wirner-Piotrowski C, Mijic M, et al
    Efficacy and safety of respiratory strength and endurance training in patients with myotonic dystrophy type 1 (DM1): a randomized controlled trial.
    J Neurol. 2025;272:626.
    >> Share

  21. ZHU W, Chen Y, Tian C, Wang J, et al
    Factors associated with early response to efgartigimod in patients with generalized myasthenia gravis: a multicenter retrospective observational study.
    J Neurol. 2025;272:622.
    >> Share

  22. YANG J, Li H, Zhang Y, Hu S, et al
    Effects of exercise on fatigue and quality of life in multiple sclerosis: a network meta-analysis and systematic review.
    J Neurol. 2025;272:621.
    >> Share

    August 2025
  23. ADAMMEK F, Gralla W, Kupjetz M, Rademacher A, et al
    Functional exercise training in persons with multiple sclerosis: a systematic review.
    J Neurol. 2025;272:590.
    >> Share

  24. PETERSSON M, Wu J, Berggren F, Schager I, et al
    Impact of disease activity on quality of life and EQ-5D-3L score in myasthenia gravis: results from the Swedish MG registry.
    J Neurol. 2025;272:562.
    >> Share

    May 2025
  25. ZHANG Y, Li G, Su H, Liang Y, et al
    Effects of exercise on balance function in people with multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials.
    J Neurol. 2025;272:405.
    >> Share

  26. ROSSINI E, Di Stefano V, Iorio R, Habetswallner F, et al
    Ravulizumab for generalized Myasthenia Gravis: a multicenter real-life experience.
    J Neurol. 2025;272:396.
    >> Share

    April 2025
  27. BLASI V, Rapisarda L, Cacciatore DM, Palumbo E, et al
    Structural and functional neuroplasticity in music and dance-based rehabilitation: a systematic review.
    J Neurol. 2025;272:329.
    >> Share

    March 2025
  28. LIU J, Liu K, Ge X, Zhou P, et al
    Flexible exoskeleton-assisted training enhances lower limb motor function after stroke: a systematic review and meta-analysis.
    J Neurol. 2025;272:274.
    >> Share

    February 2025
  29. GIL-SALCEDO A, Lunven M, Jacquemot C, Massart R, et al
    Specific contribution of cognitive and motor impairments with functional capacity and dependence in Huntington's disease.
    J Neurol. 2025;272:224.
    >> Share

  30. MOREU-VALLS A, Puig-Davi A, Martinez-Horta S, Kulisevsky G, et al
    A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in Huntington's disease.
    J Neurol. 2025;272:202.
    >> Share

  31. RUTTEN S, Bradley-Westguard A, Nicholson TR, Pick S, et al
    Outcome measurement in functional neurological disorder: A qualitative study on the views of patients, caregivers and healthcare professionals.
    J Neurol. 2025;272:189.
    >> Share

  32. KLEIN M, Einhaupl B, Grill E, Drunin G, et al
    Differences in functional outcome of COVID-19 and non-COVID-19 patients with critical illness polyneuropathy/ myopathy: a multicenter cohort study.
    J Neurol. 2025;272:197.
    >> Share

    January 2025
  33. SPEE BTM, de Vries NM, Zeggio S, Plijnaer M, et al
    Unleashing creativity in people with Parkinson's disease: a pilot study of a co-designed creative arts therapy.
    J Neurol. 2025;272:161.
    >> Share

  34. HUYNH K, Jamadar SD, Lampit A, Siddiqui MN, et al
    Feasibility and effects of cognitive training on cognition and psychosocial function in Huntington's disease: a randomised pilot trial.
    J Neurol. 2025;272:159.
    >> Share

  35. VAN DER ZWAAN KF, Feleus S, Dekkers OM, Roos RAC, et al
    Total functioning capacity scale in Huntington's disease: natural course over time.
    J Neurol. 2025;272:140.
    >> Share

    December 2024
  36. LAZZARINI SG, Mosconi B, Cordani C, Arienti C, et al
    Effectiveness of robot-assisted training in adults with Parkinson's disease: a systematic review and meta-analysis.
    J Neurol. 2024;272:22.
    >> Share

  37. YE Y, Wu K, Xu F, Li H, et al
    Effects of exercise on patients with vascular cognitive impairment based on ACSM recommendations: a systematic review of randomized controlled trials.
    J Neurol. 2024;272:31.
    >> Share

    October 2024
  38. FACCIORUSSO S, Malfitano C, Giordano M, Del Furia MJ, et al
    Effectiveness of robotic rehabilitation for gait and balance in people with multiple sclerosis: a systematic review.
    J Neurol. 2024 Oct 10. doi: 10.1007/s00415-024-12715.
    >> Share

    August 2024
  39. LIN R, Zhang JJ, Zhong L, Chan SSY, et al
    Does repetitive transcranial magnetic stimulation have a beneficial effect on improving unilateral spatial neglect caused by stroke? A meta-analysis.
    J Neurol. 2024 Aug 28. doi: 10.1007/s00415-024-12612.
    >> Share

  40. SEGURA E, Grau-Sanchez J, Cerda-Company X, Porto MF, et al
    Enriched music-supported therapy for individuals with chronic stroke: a randomized controlled trial.
    J Neurol. 2024 Aug 7. doi: 10.1007/s00415-024-12570.
    >> Share

  41. PETO D, Schmidmeier F, Katzdobler S, Fietzek UM, et al
    No evidence for effects of low-intensity vestibular noise stimulation on mild-to-moderate gait impairments in patients with Parkinson's disease.
    J Neurol. 2024;271:5489-5497.
    >> Share

  42. LI R, Sun J, Luo K, Luo N, et al
    Electroacupuncture and carbamazepine for patients with trigeminal neuralgia: a randomized, controlled, 2 x 2 factorial trial.
    J Neurol. 2024;271:5122-5136.
    >> Share

    July 2024
  43. PANE C, Di Stefano V, Cuomo N, Sarnataro A, et al
    A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients.
    J Neurol. 2024 Jul 30. doi: 10.1007/s00415-024-12588.
    >> Share

  44. HABIB AA, Klink AJ, Muppidi S, Parthan A, et al
    United States clinical practice experience with eculizumab in myasthenia gravis: symptoms, function, and immunosuppressant therapy use.
    J Neurol. 2024 Jul 25. doi: 10.1007/s00415-024-12569.
    >> Share

  45. WUEHR M, Peto D, Fietzek UM, Katzdobler S, et al
    Low-intensity vestibular noise stimulation improves postural symptoms in progressive supranuclear palsy.
    J Neurol. 2024;271:4577-4586.
    >> Share

    June 2024
  46. ZHOU Y, Ren H, Hou X, Dong X, et al
    The effect of exercise on balance function in stroke patients: a systematic review and meta-analysis of randomized controlled trials.
    J Neurol. 2024 Jun 4. doi: 10.1007/s00415-024-12467.
    >> Share

    May 2024
  47. PEITZ D, Schumann-Werner B, Hussmann K, Pinho J, et al
    Success rates of intensive aphasia therapy: real-world data from 448 patients between 2003 and 2020.
    J Neurol. 2024 May 20. doi: 10.1007/s00415-024-12429.
    >> Share

  48. BARBOSA RP, Moreau C, Rolland AS, Rascol O, et al
    The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study.
    J Neurol. 2024;271:2582-2595.
    >> Share

  49. ROCCA MA, Romano F, Tedone N, Filippi M, et al
    Advanced neuroimaging techniques to explore the effects of motor and cognitive rehabilitation in multiple sclerosis.
    J Neurol. 2024 May 1. doi: 10.1007/s00415-024-12395.
    >> Share

    April 2024
  50. NAUTA IM, van Dam M, Bertens D, Kessels RPC, et al
    Improved quality of life and psychological symptoms following mindfulness and cognitive rehabilitation in multiple sclerosis and their mediating role for cognition: a randomized controlled trial.
    J Neurol. 2024 Apr 23. doi: 10.1007/s00415-024-12327.
    >> Share

  51. LIU M, Zhu Y, Yuan Y, Wang Y, et al
    Plasma neurofilament light as a promising biomarker in neuronal intranuclear inclusion disease.
    J Neurol. 2024;271:2042-2052.
    >> Share

    January 2024
  52. NAUTA IM, Kessels RPC, Bertens D, Stam CJ, et al
    Neurophysiological brain function predicts response to cognitive rehabilitation and mindfulness in multiple sclerosis: a randomized trial.
    J Neurol. 2024 Jan 26. doi: 10.1007/s00415-024-12183.
    >> Share

  53. BLAZQUEZ-GONZALEZ P, Miron-Gonzalez R, Lendinez-Mesa A, Luengo-Gonzalez R, et al
    Efficacy of the use of video games on mood, anxiety and depression in stroke patients: preliminary findings of a randomised controlled trial.
    J Neurol. 2024 Jan 10. doi: 10.1007/s00415-023-12043.
    >> Share

    November 2023
  54. HUANG Q, Jiang X, Jin Y, Wu B, et al
    Immersive virtual reality-based rehabilitation for subacute stroke: a randomized controlled trial.
    J Neurol. 2023 Nov 10. doi: 10.1007/s00415-023-12060.
    >> Share

  55. CUI W, Li D, Yue L, Xie J, et al
    The effects of exercise dose on patients with Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.
    J Neurol. 2023;270:5327-5343.
    >> Share

    June 2023
  56. SCHNITZER L, Hansson PO, Samuelsson CM, Drummond A, et al
    Fatigue in stroke survivors: a 5-year follow-up of the Fall study of Gothenburg.
    J Neurol. 2023 Jun 15. doi: 10.1007/s00415-023-11812.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016